New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN)

Despite recent advances in radiotherapy and chemotherapy, survival rates for squamous cell carcinoma of the head and neck (SCCHN) have remained poor. The focus of SCCHN therapy has more recently shifted to the molecular level, particularly the epidermal growth factor receptor (EGFR/ErbB) pathway. Se...

Descripción completa

Detalles Bibliográficos
Autor principal: Agulnik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466428/
https://www.ncbi.nlm.nih.gov/pubmed/22252310
http://dx.doi.org/10.1007/s12032-012-0159-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466428/
https://www.ncbi.nlm.nih.gov/pubmed/22252310
http://dx.doi.org/10.1007/s12032-012-0159-2

Ejemplares similares